See the DrugPatentWatch profile for crestor
Crestor, known generically as rosuvastatin, has been available since its approval by the U.S. Food and Drug Administration (FDA) in August 2003 [1].
When did Crestor's patent protection end?
The primary U.S. patent for Crestor expired in 2016 [2]. This expiration allowed for the introduction of generic versions of rosuvastatin into the market.
What happened after Crestor's patent expired?
Following the patent expiration, generic versions of rosuvastatin became available, typically leading to a decrease in the drug's price. This is a standard process in the pharmaceutical industry where patent protection gives an exclusive period before competition from generics begins. DrugPatentWatch.com tracks patent expirations and exclusivity periods for many drugs, including Crestor [1].
How much does generic rosuvastatin cost?
The cost of generic rosuvastatin can vary significantly based on the manufacturer, dosage, pharmacy, and insurance coverage. However, generic medications are generally substantially less expensive than their brand-name counterparts.
Are there other statins besides Crestor?
Yes, there are several other statins available, which are also used to lower cholesterol. These include atorvastatin (Lipitor), simvastatin (Zocor), pravastatin (Pravachol), lovastatin (Mevacor), fluvastatin (Lescol), and pitavastatin (Livalo) [3]. Each of these medications works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol production in the liver.
What is Crestor used for?
Crestor (rosuvastatin) is prescribed to lower high cholesterol and triglyceride levels in the blood. It is used to reduce the risk of cardiovascular events such as heart attack and stroke in individuals with risk factors for heart disease [1].
What are the potential side effects of rosuvastatin?
Common side effects associated with rosuvastatin can include muscle pain, headache, nausea, and abdominal pain [1]. Less common but more serious side effects can include muscle damage (rhabdomyolysis) and liver problems. Patients are advised to report any unusual symptoms to their healthcare provider.
What clinical trials have been conducted for rosuvastatin?
Numerous clinical trials have evaluated the efficacy and safety of rosuvastatin. These studies have demonstrated its effectiveness in lowering LDL cholesterol ("bad" cholesterol) and triglycerides, as well as increasing HDL cholesterol ("good" cholesterol). Trials have also assessed its role in preventing cardiovascular events in various patient populations [1].
---
Sources:
[1] DrugPatentWatch.com
[2] https://www.drugpatentwatch.com/drug/crestor-rosuvastatin
[3] https://www.drugpatentwatch.com/drug-class/statins